Skip to main content
Premium Trial:

Request an Annual Quote

IP Update: Recent Patents Awarded to Alnylam, Alcon, and More

Premium

Title: siRNA Compositions and Methods for Potently Inhibiting Viral Infection

Patent Number: 8,664,188

Filed: Dec. 11, 2009

Lead Inventor: Bojian Zheng, Xiangxue Group


Title: RNA Interference in Skin Indications

Patent Number: 8,664,189

Filed: Sept. 22, 2009

Lead Inventor: Anastasia Khvorova, RXi Pharmaceuticals


Title: Mutator Activity Induced by microRNA-155 Links Inflammation and Cancer

Patent Number: 8,664,192

Filed: March 7, 2012

Inventor: Carlo Croce, Ohio State University (Microlin Bio)


Title: Compositions and Methods for Inhibiting Expression of Factor VII Gene

Patent Number: 8,664,193

Filed: Sept. 14, 2012

Lead Inventor: Antonin de Fourgerolles, Alnylam Pharmaceuticals


Title: Interfering RNA Delivery Systems and Uses Thereof

Patent Number: 8,664,375

Filed: Dec. 14, 2010

Inventor: Jon Chatterton, Alcon


Title: Use of Two microRNA [Molecules] in Lung Cancer Prognosis and Medicine Preparation

Patent Number: 8,664,191

Filed: July 9, 2009

Lead Inventor: Qimin Zhan, Chinese Academy of Medical Services

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.